Another approach currently in development is the Flu-v CD8+ T cell-activating vaccine (213) containing four 21–35 amino acid-long peptides from internal influenza proteins, which can potentially bind to multiple HLA allelic forms, including the highly prominent HLA-A*02:01. The gene discussed is CD8A; the disease is influenza.